{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:51:17Z","timestamp":1776153077116,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.arcmed.2023.102841","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T19:51:19Z","timestamp":1688154679000},"page":"102841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Primary Pituitary Carcinoids Do Not Exist: A Reappraisal in the Era of Pituitary Neuroendocrine Tumours"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3310-1521","authenticated-orcid":false,"given":"Eleni","family":"Armeni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystallenia I.","family":"Alexandraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Roncaroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1176-6186","authenticated-orcid":false,"given":"Ashley B.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2023.102841_bib0001","first-page":"98","article-title":"The eminent German pathologist Siegfried Oberndorfer (1876\u20131944) and his landmark work on carcinoid tumors","volume":"24","author":"Tsoucalas","year":"2011","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0002","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.3390\/ijms24021418","article-title":"The Complex Histopathological and Immunohistochemical Spectrum of Neuroendocrine Tumors-An Overview of the Latest Classifications","volume":"24","author":"Gheorghi\u0219an-G\u0103l\u0103\u021beanu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2023.102841_bib0003","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0004","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO Classification of Pituitary Tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0005","unstructured":"WHO_classification_of_Tumours_Editorial_Board. Endocrine and Neuroendocrine Tumours. 8. 5th ed. Lyon, France 2022."},{"key":"10.1016\/j.arcmed.2023.102841_bib0006","doi-asserted-by":"crossref","first-page":"e13146","DOI":"10.1111\/jne.13146","article-title":"European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease","volume":"34","author":"Grozinsky-Glasberg","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0007","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11102-019-01015-0","article-title":"Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution","volume":"23","author":"Asa","year":"2020","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102841_bib0008","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00428-019-02655-0","article-title":"A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal","volume":"475","author":"Villa","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.arcmed.2023.102841_bib0009","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11102-019-00988-2","article-title":"A tale of pituitary adenomas: to NET or not to NET : Pituitary Society position statement","volume":"22","author":"Ho","year":"2019","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102841_bib0010","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11102-019-01027-w","article-title":"The tale in evolution: clarity, consistency and consultation, not contradiction and confusion","volume":"23","author":"Ho","year":"2020","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102841_bib0011","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11102-022-01235-x","article-title":"The NETting of pituitary adenoma: a gland illusion","volume":"25","author":"Ho","year":"2022","journal-title":"Pituitary"},{"issue":"Suppl","key":"10.1016\/j.arcmed.2023.102841_bib0012","article-title":"Neuroendocrine embryology and the APUD concept","volume":"5","author":"Pearse","year":"1976","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102841_bib0013","series-title":"Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2022","article-title":"APUDoma. StatPearls","author":"Elmaaz","year":"2022"},{"key":"10.1016\/j.arcmed.2023.102841_bib0014","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1679\/aohc.45.409","article-title":"The neural crest: its relations with APUD and paraneuron concepts","volume":"45","author":"Ayer-Le Lievre","year":"1982","journal-title":"Arch Histol Jpn"},{"key":"10.1016\/j.arcmed.2023.102841_bib0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2613.2011.00767.x","article-title":"Classification and functions of enteroendocrine cells of the lower gastrointestinal tract","volume":"92","author":"Gunawardene","year":"2011","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0016","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000096997","article-title":"Evolution of the diffuse neuroendocrine system\u2013clear cells and cloudy origins","volume":"84","author":"Modlin","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.arcmed.2023.102841_bib0017","first-page":"322","article-title":"The diffuse neuroendocrine (APUD) system","volume":"37","author":"Launay","year":"1983","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.arcmed.2023.102841_bib0018","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41379-021-00820-y","article-title":"Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification","volume":"34","author":"Asa","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0019","first-page":"447","article-title":"The neuroendocrine phenotype, cellular plasticity, and the search for genetic switches: redefining the diffuse neuroendocrine system","volume":"23","author":"Day","year":"2002","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.arcmed.2023.102841_bib0020","series-title":"The Spectrum of Neuroendocrine Neoplasia: A Practical Approach to Diagnosis, Classification and Therapy","first-page":"389","article-title":"Cytology of Neuroendocrine Neoplasms","author":"Bongiovanni","year":"2021"},{"key":"10.1016\/j.arcmed.2023.102841_bib0021","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.neo.2017.09.002","article-title":"Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas","volume":"19","author":"Oronsky","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.arcmed.2023.102841_bib0022","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.ph.52.030190.003205","article-title":"Pathways to Regulated Exocytosis in Neurons","volume":"52","author":"P De Camilli","year":"1990","journal-title":"Annual Review of Physiology"},{"key":"10.1016\/j.arcmed.2023.102841_bib0023","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0b013e3181ec124e","article-title":"The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems","volume":"39","author":"Klimstra","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.arcmed.2023.102841_bib0024","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","article-title":"Ki-67: more than a proliferation marker","volume":"127","author":"Sun","year":"2018","journal-title":"Chromosoma"},{"key":"10.1016\/j.arcmed.2023.102841_bib0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.arcmed.2023.102841_bib0026","unstructured":"Klimstra DS, Kloppel G, La Rosa S, et\u00a0al. Digestive System Tumours 2019 2019."},{"key":"10.1016\/j.arcmed.2023.102841_bib0027","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","article-title":"TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system","volume":"449","author":"Rindi","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.arcmed.2023.102841_bib0028","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.dld.2020.08.031","article-title":"Update on gastroenteropancreatic neuroendocrine tumors","volume":"53","author":"Andreasi","year":"2021","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.arcmed.2023.102841_bib0029","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","article-title":"Overview of the 2017 WHO Classification of Pituitary Tumors","volume":"28","author":"Mete","year":"2017","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0030","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.3390\/molecules16053618","article-title":"Molecular morphology of pituitary cells, from conventional immunohistochemistry to fluorescein imaging","volume":"16","author":"Matsuno","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.arcmed.2023.102841_bib0031","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1038\/s41467-020-19012-4","article-title":"Single-cell transcriptomics identifies divergent developmental lineage trajectories during human pituitary development","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.arcmed.2023.102841_bib0032","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/nan.12568","article-title":"Invited Review: Pathology of pituitary neuroendocrine tumours: present status, modern diagnostic approach, controversies and future perspectives from a neuropathological and clinical standpoint","volume":"46","author":"Manojlovic-Gacic","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0033","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/030089168807400118","article-title":"Pituitary metastasis from malignant bronchial carcinoid","volume":"74","author":"Rossi","year":"1988","journal-title":"Tumori"},{"key":"10.1016\/j.arcmed.2023.102841_bib0034","first-page":"414","article-title":"A metastatic pituitary carcinoid tumor successfully treated with gamma knife radiosurgery","volume":"64","author":"Huang","year":"2001","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"10.1016\/j.arcmed.2023.102841_bib0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1023\/B:PITU.0000044627.63261.b4","article-title":"Malignant bronchial carcinoid tumor metastatic to the pituitary in a thyroid carcinoma patient: successful treatment with surgery, radiotherapy and somatostatin analog","volume":"7","author":"Shimon","year":"2004","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102841_bib0036","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4158\/EP.13.3.291","article-title":"Pulmonary atypical carcinoid tumor with metastatic involvement of the pituitary gland causing functional hypopituitarism","volume":"13","author":"Jonnakuty","year":"2007","journal-title":"Endocr Pract"},{"key":"10.1016\/j.arcmed.2023.102841_bib0037","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11102-012-0388-6","article-title":"Bronchial carcinoid tumors metastatic to the sella turcica and review of the literature","volume":"15","author":"Moshkin","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102841_bib0038","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/jc.2006-0610","article-title":"Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma","volume":"91","author":"Nasr","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102841_bib0039","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11102-007-0053-7","article-title":"Metastatic pancreatic neuroendocrine tumor presenting as a pituitary space occupying lesion: a case report","volume":"11","author":"Gur","year":"2008","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102841_bib0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11102-007-0038-6","article-title":"Treatment of a pituitary metastasis from a neuroendocrine tumour: case report and literature review","volume":"11","author":"Goglia","year":"2008","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102841_bib0041","doi-asserted-by":"crossref","first-page":"K5","DOI":"10.1530\/EJE-13-0622","article-title":"Carcinoid syndrome caused by a serotonin-secreting pituitary tumour","volume":"170","author":"Lyngg\u00e5rd","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0042","first-page":"209","article-title":"Pituitary carcinoid coexisting with systemic lupus erythematosus: A rare combination","volume":"29","author":"Bhambhani","year":"2016","journal-title":"Natl Med J India"},{"key":"10.1016\/j.arcmed.2023.102841_bib0043","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/sni.sni_450_16","article-title":"Primary pituitary neuroendocrine tumor: Case report and literature review","volume":"8","author":"Nasi","year":"2017","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.arcmed.2023.102841_bib0044","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12957-016-0887-4","article-title":"Primary intracranial neuroendocrine tumor: two case reports","volume":"14","author":"Liu","year":"2016","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","article-title":"A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up","volume":"126","author":"Trouillas","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0046","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1530\/EJE-22-0440","article-title":"Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients","volume":"187","author":"Burman","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0047","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1530\/EJE-13-1031","article-title":"Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies","volume":"170","author":"Raverot","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0048","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas","volume":"178","author":"Raverot","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0049","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2016-4061","article-title":"Outcome of Nonfunctioning Pituitary Adenomas That Regrow After Primary Treatment: A Study From Two Large UK Centers","volume":"102","author":"Tampourlou","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102841_bib0050","doi-asserted-by":"crossref","first-page":"R559","DOI":"10.1530\/ERC-18-0228","article-title":"Aggressive and malignant pituitary tumours: state-of-the-art","volume":"25","author":"Dworakowska","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2023.102841_bib0051","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","article-title":"A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0052","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12022-017-9484-5","article-title":"Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours","volume":"28","author":"Lam","year":"2017","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0053","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/ERC-15-0310","article-title":"Appendiceal neuroendocrine neoplasms: diagnosis and management","volume":"23","author":"Alexandraki","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2023.102841_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2021.151724","article-title":"Rising incidence of appendiceal neoplasms over time: Does pathological handling of appendectomy specimens play a role?","volume":"52","author":"Bahmad","year":"2021","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000443165","article-title":"ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas)","volume":"103","author":"Pape","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.arcmed.2023.102841_bib0056","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/S1470-2045(21)00572-6","article-title":"(177)Lu-Dotatate plus long-acting octreotide versus high\u2011dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial","volume":"22","author":"Strosberg","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0057","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1200\/JCO.2007.15.2553","article-title":"Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival","volume":"26","author":"Kwekkeboom","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2023.102841_bib0058","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000494760","article-title":"Targeted Alpha Particle Therapy for Neuroendocrine Tumours: The Next Generation of Peptide Receptor Radionuclide Therapy","volume":"108","author":"Navalkissoor","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.arcmed.2023.102841_bib0059","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/ERC-19-0263","article-title":"Neoplastic metastases to the endocrine glands","volume":"27","author":"Angelousi","year":"2020","journal-title":"Endocr Relat Cancer"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440923000796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440923000796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:14:07Z","timestamp":1741184047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440923000796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0188440923000796"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2023.102841","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Pituitary Carcinoids Do Not Exist: A Reappraisal in the Era of Pituitary Neuroendocrine Tumours","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2023.102841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102841"}}